[EN] AMINO - PYRIMIDINE COMPOUNDS AS INHIBITORS OF TBKL AND/OR IKK EPSILON<br/>[FR] COMPOSÉS D'AMINO-PYRIMIDINE EN TANT QU'INHIBITEURS DE TBKL ET OU D'IKK EPSILON
申请人:MYREXIS INC
公开号:WO2011046970A1
公开(公告)日:2011-04-21
The invention relates to certain amino-pyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).
这项发明涉及抑制TBK1和/或IKK epsilon的某些氨基嘧啶化合物,因此可能在治疗炎症、癌症、感染性休克和/或原发性开角青光眼(POAG)中找到应用。